Retour
Fourchette du Jour
13,60 €
13,78 €
Fourchette 52 Semaines
12,72 €
19,09 €
Volume
1 089 525
Moyenne 50J / 200J
14,27 €
/
14,52 €
Clôture Précédente
13,53 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 9,3 | 0,4 |
| P/B | 1,3 | 2,9 |
| ROE % | 13,5 | 3,8 |
| Net Margin % | 25,3 | 3,9 |
| Rev Growth 5Y % | 0,9 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 0,89% annually over 5 years — modest growth
Earnings declined -48,24% over the past year
ROE of 13,53% — decent returns on equity
Net margin of 25,33% shows strong profitability
Debt/Equity of 0,02 — conservative balance sheet
Generating 84,29M in free cash flow
Croissance
Revenue Growth (5Y)
0,89%
Revenue (1Y)-6,16%
Earnings (1Y)-48,24%
FCF Growth (3Y)-30,82%
Qualité
Return on Equity
13,53%
ROIC9,20%
Net Margin25,33%
Op. Margin23,05%
Sécurité
Debt / Equity
0,02
Current Ratio9,88
Interest Coverage0,00
Valorisation
P/E Ratio
9,27
P/B Ratio1,27
EV/EBITDA6,80
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6,16% | Revenue Growth (3Y) | -13,23% |
| Earnings Growth (1Y) | -48,24% | Earnings Growth (3Y) | -31,15% |
| Revenue Growth (5Y) | 0,89% | Earnings Growth (5Y) | -13,16% |
| Profitability | |||
| Revenue (TTM) | 370,50M | Net Income (TTM) | 93,83M |
| ROE | 13,53% | ROA | 12,24% |
| Gross Margin | 78,54% | Operating Margin | 23,05% |
| Net Margin | 25,33% | Free Cash Flow (TTM) | 84,29M |
| ROIC | 9,20% | FCF Growth (3Y) | -30,82% |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 9,88 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 9,27 | P/B Ratio | 1,27 |
| P/S Ratio | 2,35 | PEG Ratio | -0,28 |
| EV/EBITDA | 6,80 | Dividend Yield | 0,00% |
| Market Cap | 869,92M | Enterprise Value | 580,61M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 370,50M | 394,82M | 492,05M | 454,27M | 357,57M |
| Net Income | 93,83M | 181,28M | 197,92M | 161,52M | 164,97M |
| EPS (Diluted) | 1,43 | 2,25 | 2,30 | 1,89 | 1,92 |
| Gross Profit | 290,97M | 317,07M | 411,34M | 380,79M | 303,97M |
| Operating Income | 85,39M | 112,53M | 195,66M | 197,85M | 167,48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 766,43M | 785,67M | 863,29M | 644,41M | 478,54M |
| Total Liabilities | 83,23M | 81,85M | 75,91M | 89,79M | 62,74M |
| Shareholders' Equity | 683,20M | 703,81M | 787,37M | 554,62M | 415,80M |
| Total Debt | 13,24M | 7,82M | 9,02M | 4,96M | 4,52M |
| Cash & Equivalents | 302,54M | 155,33M | 144,41M | 97,54M | 68,14M |
| Current Assets | 698,62M | 714,45M | 845,33M | 629,37M | 470,11M |
| Current Liabilities | 70,74M | 69,85M | 64,14M | 82,02M | 51,85M |